Literature DB >> 28379031

Experimental models of hyperlipoproteinemia and atherosclerosis.

R Poledne1, L Jurčíková-Novotná.   

Abstract

The first experimental model of atherosclerosis (in rabbits) is more than hundred years old. Several animal species have been used to produce hyperlipoproteinemia and possible atherosclerosis. The gene manipulation produced the most used models recently. This review acknowledges the extensive study of atherosclerotic changes in experimental models of hyperlipoproteinemia and atherosclerosis to come to light thus far and the purpose here is not only to summarize the published data but also to try to add some details of our experience in using these models. In addition to rabbit (the old but also improved model by reno-vascular hypertension) dog, birds, pig, hamster, mice, rat and non-human primate's animal models are described. The gene manipulation produced the most used models two decades ago. Germline genetically engineered (without apoE or LDL receptor genes) animals have become the most used models producing atherosclerotic changes in the aorta. Recent new models also producing atherosclerotic changes but without germline genetic manipulation are also described.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28379031     DOI: 10.33549/physiolres.933585

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

Review 1.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 2.  Dietary cholesterol does not break your heart but kills your liver.

Authors:  Gerhard P Püschel; Janin Henkel
Journal:  Porto Biomed J       Date:  2019-06-29

3.  A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys.

Authors:  Megumi Morimoto; Masuo Yamaoka; Takahito Hara
Journal:  Pharmacol Res Perspect       Date:  2020-02

4.  Temporal Requirement for the Protective Effect of Dietary Cholesterol against Alcohol-Induced Vasoconstriction.

Authors:  Olga Seleverstov; Kelsey North; Maria Simakova; Shivantika Bisen; Alexandra Bickenbach; Zoran Bursac; Alex M Dopico; Anna N Bukiya
Journal:  J Drug Alcohol Res       Date:  2020-10-20

5.  Global DNA methylation in rats´ liver is not affected by hypercholesterolemic diet.

Authors:  L Jurcikova-Novotna; L Mrazova; K Mičová; D Friedecký; J A Hubacek; R Poledne
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

6.  Preclinical Pharmacokinetics and Pharmacodynamics of Coptidis Preparation in Combination with Lovastatin in High-Fat Diet-Induced Hyperlipidemic Rats.

Authors:  Wen-Ya Peng; Andy C Huang; Chin-Tsung Ting; Tung-Hu Tsai
Journal:  ACS Omega       Date:  2021-06-10

7.  Inclusion of endophenotypes in a standard GWAS facilitate a detailed mechanistic understanding of genetic elements that control blood lipid levels.

Authors:  Qianqian Zhang; Zexi Cai; Marie Lhomme; Goutam Sahana; Philippe Lesnik; Maryse Guerin; Merete Fredholm; Peter Karlskov-Mortensen
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.